Home  /  Resource Library  /  Delayed COVID-19 Respiratory Failure in Lymphoma Patients on Rituximab-based Chemoimmunotherapy

Delayed COVID-19 Respiratory Failure in Lymphoma Patients on Rituximab-based Chemoimmunotherapy

Case report of 3 patients with follicular lymphoma who developed severe COVID-19.